Cheryl Peretz

Dr. Cheryl Peretz is a pediatric hematologist-oncologist at the University of California San Francisco, specializing in difficult-to-treat blood cancers in children. Her clinical focus includes various leukemias, while her research centers on myeloid leukemia, particularly acute myeloid leukemia (AML), and the role of genetic alterations in treatment resistance. She investigates mixed phenotype acute leukemia and genetically predisposed leukemias using advanced genomic techniques.

Education:

• University of Pennsylvania, BA (2008) in Biological Basis of Behavior and Hispanic Studies
• University of Connecticut, MD (2012) in Medicine
• University of California San Francisco, Residency (2015) in Pediatrics
• Children’s Hospital and Research Center, Oakland, Fellowship (2019) in Pediatric Hematology/Oncology
• University of California San Francisco, Post-doc (2022) in AML

In her research, Peretz employs single-cell sequencing and multiomic approaches to understand leukemia heterogeneity, clonal evolution, and drug resistance mechanisms. Her work has implications for precision medicine and novel therapeutic strategies.

Scientific Awards:

• ASH Abstract Achievement Award (2021, 2019)
• Julius R. Kravens Award for Clinical Excellence (2013)
• Gold Humanism Honor Society (2009)
• Pi Gamma Mu Honor Society of the Social Sciences